Hereditary non-polyposis colorectal cancer (HNPCC) is known to be associated with several extracolonic cancers, e.g., cancers of the endometrium, stomach, urinary tract, small bowel and ovary. An association between HNPCC and brain tumours has also been reported, although previous risk analysis did
Missense Polymorphisms in theAdenomatous Polyposis ColiGene and Colorectal Cancer Risk
โ Scribed by Sean P. Cleary; Hyeja Kim; Marina E. Croitoru; Mark Redston; Julia A. Knight; Steven Gallinger; Robert Gryfe
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 186 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0012-3706
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Chronic inflammation is an established risk factor for colorectal cancer (CRC), and polymorphisms in genes regulating inflammatory processes appear to alter the risk for neoplasia and the efficacy of nonsteroidal antiโinflammatory drugs in CRC chemoprevention. We examined the associatio
## Abstract Patients diagnosed with HNPCC harbouring a confirmed germline mutation in DNA mismatch repair (MMR) genes have an 80% lifetime risk of developing an epithelial malignancy. There is, however, considerable variation in the age of disease onset in these patients. Insulinโlike growth factor
Identification of hereditary non-polyporis colorectal cancer (HNPCC) indicates theoretical life-time risks of 50% for the descendants of an affected family member and of 100% for the true gene carriers. However, besides colorectal cancer (CRC), many other cancer types and sites are also involved, wh
## Abstract With an incidence of about 300โ000 new cases colorectal cancer (CRC) is the second leading cause of cancerโrelated death in Europe and the United States. Environmental and genetic factors influence CRC risk. Hypoxiaโinducible factorโ1 (HIFโ1), a heterodimeric protein composed of two sub